famotidine
Selected indexed studies
- Famotidine Repurposing for Novel Corona Virus Disease of 2019: A Systematic Review. (Drug Res (Stuttg), 2021) [PMID:33757133]
- Famotidine increases cellular phospho-tyrosine levels. (Biochem Biophys Res Commun, 2024) [PMID:39362028]
- Famotidine in gastroesophageal reflux disease (GERD). (Hepatogastroenterology, 1992) [PMID:1577391]
_Worker-drafted node — pending editorial review._
Connections
famotidine is a side effect of
Sources
- Famotidine Repurposing for Novel Corona Virus Disease of 2019: A Systematic Review. (2021) pubmed
- Famotidine increases cellular phospho-tyrosine levels. (2024) pubmed
- Famotidine in gastroesophageal reflux disease (GERD). (1992) pubmed
- Clinical pharmacokinetics of famotidine. (1991) pubmed
- Famotidine in the management of schizophrenia. (1999) pubmed
- Famotidine Enhances Rifampicin Activity against Acinetobacter baumannii by Affecting OmpA. (2023) pubmed
- Famotidine-induced retinopathy. (2006) pubmed
- Famotidine. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseases. (1989) pubmed
- Comparison of famotidine with cimetidine and ranitidine. (1988) pubmed
- Famotidine activates the vagus nerve inflammatory reflex to attenuate cytokine storm. (2022) pubmed